Difference in Metabolomic Response to Exercise between Patients with and without Hypertrophic Cardiomyopathy

Yuichi J Shimada1,2, Jaya Batra3, Stephanie M Kochav3

  • 1Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA. ys3053@cumc.columbia.edu.

Insights

Hypertrophic cardiomyopathy (HCM) does not alter cardiac metabolism at rest. Exercise reveals significant metabolic pathway differences in HCM patients, impacting aminoacyl-tRNA biosynthesis and nitrogen metabolism.

Area of Science:

  • Cardiology
  • Metabolomics
  • Biochemistry

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
  • The impact of HCM on cardiac metabolic pathways during physiological stress remains poorly understood.

Purpose of the Study:

  • To investigate the effects of hypertrophic cardiomyopathy on cardiac metabolic pathways at rest and during exercise.
  • To identify specific metabolic pathways dysregulated in HCM patients under exercise stress.

Main Methods:

  • A case-control study involving 15 HCM patients and 2 control groups.
  • Comprehensive metabolomic profiling of 210 metabolites at rest and peak exercise.
  • Statistical analysis including partial least squares discriminant analysis and pathway enrichment analysis.

Main Results:

  • No significant differences in metabolomic profiles were observed between HCM cases and controls at rest.
  • Significant exercise-induced alterations in metabolomic profiles were detected in HCM patients (p < 0.05).
  • Affected pathways include aminoacyl-tRNA biosynthesis, nitrogen metabolism, glycine/serine/threonine metabolism, and arginine/proline metabolism.

Conclusions:

  • Hypertrophic cardiomyopathy does not significantly alter cardiac metabolism at rest.
  • Exercise stress unmasks significant differential regulation of key metabolic pathways in HCM patients.
  • These findings highlight exercise-induced metabolic disturbances as a potential factor in HCM pathophysiology.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
261
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
211
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.7K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
381
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
317